|
Ibuprofen (750 mg)
|
|
|
Ibuprofen Related Compound C (0.2 mL/ampule; 3 ampules) (4-isobutylacetophenone)
|
|
|
Ibuprofen Related Compound J (25 mg) (2-(4-Isobutyrylphenyl)propanoic acid)
|
|
|
Ibutilide Fumarate (100 mg)
|
|
|
Ibutilide Related Compound A (20 mg) (N-Ethyl-N-heptyl-4-[4-(methylsulfonamido)phenyl]-4-oxobutanamide)
|
|
|
Ibutilide Related Compound B (20 mg) (N-Ethyl-N-heptyl-4-hydroxy-4-[4-(methylsulfonamido)phenyl]butanamide)
|
|
|
Idarubicin Hydrochloride (50 mg)
|
|
|
Idoxuridine (250 mg)
|
|
|
Ifosfamide (500 mg)
|
|
|
イロペリドン
販売終了
|
|
|
イロペリドン関連化合物 A ([4'-(3-クロロプロポキシ)-3'-メトキシ]アセトフェノン)
販売終了
|
|
|
Imidazole (200 mg) (1H-Imidazole)
|
|
|
Imidurea (200 mg)
|
|
|
Iminodibenzyl (25 mg) (10,11-Dihydro-5H-dibenzo[b,f]azepine)
|
|
|
Imipenem Monohydrate (100 mg)
|
|
|
Imipramine Hydrochloride (200 mg)
|
|
|
Imiquimod (200 mg)
|
|
|
Imiquimod Related Compound A (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline)
|
|
|
Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide)
|
|
|
Imiquimod Related Compound C (25 mg) (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline)
|
|
|
Imiquimod Related Compound D (25 mg) (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine)
|
|
|
Imipramine Pamoate (300 mg)
|
|
|
Indapamide (500 mg)
|
|
|
Indapamide Related Compound A (50 mg) (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide)
|
|
|
Indigotindisulfonate Sodium (750 mg)
|
|
|
Indinavir (100 mg)
|
|
|
Indinavir System Suitability (100 mg)
|
|
|
Indocyanine Green (100 mg)
|
|
|
Inositol (500 mg)
|
|
|
Indomethacin (200 mg)
|
|
|
インスリンヒト
販売終了
|
|
|
Iodipamide (200 mg)
|
|
|
Iodixanol (200 mg)
|
|
|
Iodixanol Related Compound C (25 mg) (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
|
|
|
Iodixanol Related Compound D (50 mg) (5-[Acetyl(2-hydroxy-3-methoxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
|
|
|
Iodixanol Related Compound E (25 mg) (5-{N-[3-(N-{3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide)
|
|
|
o-Iodohippuric Acid (100 mg)
|
|
|
Iodoquinol (100 mg)
|
|
|
イオヘキソール
|
|
|
Iohexol Related Compound A (100 mg) (5-(acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
|
|
|
Iohexol Related Compound B (50 mg) (5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
|
|
|
Iohexol Related Compound C (50 mg) (N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide)
|
|
|
Iopamidol (200 mg)
|
|
|
Iopamidol Related Compound A (50 mg) (N,N'-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide)
|
|
|
Iopamidol Related Compound B (50 mg) (5-Glycolamido-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide)
|
|
|
Iopamidol Related Compound C (40 mg) (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide)
|
|
|
Iopromide (400 mg)
|
|
|
Iopromide Related Compound A (50 mg) (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide)
|
|
|
Iopromide Related Compound B (50 mg) (5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide)
|
|
|
Iothalamic Acid (200 mg)
|
|
|
Ioversol (200 mg)
|
|
|
Ioversol Related Compound A (5-アミノ-N,N'-ビス(2,3-ジヒドロキシプロピル)-2,4,6-トリヨードイソフタルアミド)
販売終了
|
|
|
Ioversol Related Compound B (50 mg) (N,N'-Bis(2,3-dihydroxypropyl)-5-{[N-(2-hydroxyethyl)amino]-2-oxoethoxy}-2,4,6-triiodoisophthalamide)
|
|
|
Ioxaglic Acid (100 mg)
|
|
|
イオキシラン
販売終了
|
|
|
Ioxilan Related Compound A (5-アミノ-2,4,6-トリヨード-3N-(2-ヒドロキシエチル)カルバモイル安息香酸)
販売終了
|
|
|
Ipratropium Bromide (200 mg)
|
|
|
Ipratropium Bromide Related Compound A (10 mg) ((1R,3r,5S,8r)-3-Hydroxy-8-isopropyl-8-methyl-8-azabicyclo[3.2.1]octan-8-ium bromide)
|
|
|
Ipratropium Bromide Related Compound B (10 mg) ((1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide)
|
|
|
Ipratropium Bromide Related Compound C (15 mg) ((2-RS)-3-hydroxy-2-phenylpropanoic acid)
|
|
|
Irinotecan Hydrochloride (100 mg)
|
|
|
Irinotecan Related Compound A (10 mg) ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
|
|
|
Irinotecan Related Compound B (10 mg) ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
|
|
|
Irinotecan Related Compound C (10 mg) (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride)
|
|
|
Irinotecan Related Compound D (15 mg) ((R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate)
|
|
|
Irinotecan Related Compound E (15 mg) ((S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
|
|
|
Irbesartan (200 mg)
|
|
|
Irbesartan Related Compound A (25 mg) (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide)
|
|
|
Amiloxate (Isoamyl Methoxycinnamate) (750 mg/ampule)
|
|
|
Isobutyl Acetate (1.2 mL/ampule; 3 ampules)
|
|
|
Isobutylidene Diurea (300 mg) (1,1'-(2-Methylpropane-1,1-diyl)diurea)
|
|
|
Isobutyl Heptanoate (5 x 0.5 mL)
|
|
|
Isobutyl Isobutyrate (5 x 0.5 mL)
|
|
|
イソエタリン塩酸塩
販売終了
|
|
|
Isoflupredone Acetate (200 mg)
|
|
|
Isoflurane (1 mL)
|
|
|
Isoflurane Related Compound A (0.1 mL) (1-Chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether)
|
|
|
Isoflurane Related Compound B (0.1 mL) (2,2,2-Trifluoroethyl difluoromethyl ether)
|
|
|
L-Isoleucine (200 mg)
|
|
|
Isomalathion (50 mg) (Diethyl 2-{[methoxy(methylthio)phosphoryl]thio}succinate)
|
|
|
Isomalt (200 mg)
|
|
|
Isomaltulose (5 g)
|
|
|
Isometheptene Mucate (200 mg)
|
|
|
Isonaringin (30 mg) ((RS)-5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside)
|
|
|
Isoniazid (200 mg)
|
|
|
Isopropamide Iodide (200 mg)
|
|
|
Isopropyl Acetate (1.2 mL/ampule; 3 ampules)
|
|
|
Isopropyl Isostearate (3 x 1 mL)
|
|
|
Isopropyl Myristate (5 x 100 mg)
|
|
|
Isopropyl Palmitate (500 mg)
|
|
|
Isoproterenol Hydrochloride (125 mg)
|
|
|
Isopteropodine (20 mg)
|
|
|
Isorhamnetin (30 mg)
|
|
|
Isosorbide (78% solution, 1 g)
|
|
|
Isostearyl Isostearate (1 mL)
|
|
|
Isotretinoin (200 mg)
|
|
|
Isoxsuprine Hydrochloride (200 mg)
|
|
|
Isradipine (200 mg)
|
|
|
Isradipine Related Compound A (15 mg) (Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylate)
|
|
|
Itraconazole (100 mg)
|
|
|
Itraconazole System Suitability Mixture (25 mg)
|
|
|
Ivermectin (200 mg)
|
|
|
Ixabepilone (100 mg)
|
|
|
Ixabepilone System Suitability Mixture (10 mg)
|
|
|
Indomethacin Related Compound A (25 mg) (2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid)
|
|
|
Kaempferol (15 mg) (3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one)
|
|
|
Kaempferol-3-O-Robinoside-7-O-Glucoside (20 mg)
|
|
|
Kanamycin Sulfate (200 mg)
|
|
|
Kawain (200 mg)
|
|
|
Ketamine Related Compound A (50 mg) (1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol)
|
|
|
Ketorolac Related Compound A (20 mg) (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide)
|
|
|
Ketorolac Related Compound B (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol)
|
|
|
Ketorolac Related Compound C (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-one)
|
|
|
Ketorolac Related Compound D (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizine)
|
|
|
Ketoconazole (200 mg)
|
|
|
Ketoprofen Related Compound C (20 mg) (2-(3-carboxyphenyl)propionic acid)
|
|
|
Ketoprofen Related Compound D (20 mg) (3-Acetylbenzophenone) (COLD SHIPMENT REQUIRED)
|
|
|
Ketoprofen Related Compound F (20 mg) (3-(1-Cyanoethyl)benzophenone)
|
|
|
Krill Oil (2 g)
|
|
|
Ketoprofen (200 mg)
|
|
|
Ketoprofen Related Compound A (25 mg) (alpha-methyl-3-(4-methylbenzoyl) benzeneacetic acid)
|
|
|
Ketorolac Tromethamine (200 mg)
|
|
|
Lagerstroemia speciosa Leaf Dry Extract (1g)
|
|
|
Levomedetomidine (25 mg) ((R)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride) (25 mg)
|
|
|
Lovastatin Epimer Mixture (25 mg) (Epilovastatin and Lovastatin 1:1 Mixture)
|
|
|
Low Molecular Weight Heparin for Bioassays (5 mg)
|
|
|
Low Molecular Weight Heparin for Boron Analysis (300 mg)
|
|
|
Low-substituted Hydroxypropyl Cellulose (100 mg)
|
|
|
Labetalol Hydrochloride (200 mg)
|
|
|
Lactitol (500 mg)
|
|
|
Lactase (200 mg) (COLD SHIPMENT REQUIRED)
|
|
|
Lactose Monohydrate (500 mg)
|
|
|
Lactic Acid (1.5 mL/ampule; 3 ampules)
|
|
|
Lamotrigine (150 mg)
|
|
|
Lamotrigine Related Compound B (20 mg) (2,3-dichlorobenzoic acid)
|
|
|
Lamotrigine Related Compound C (10 mg) (3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one)
|
|
|
Lamotrigine Related Compound D (10 mg) (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide)
|
|
|
Lactulose (1 g)
|
|
|
Lactobionic Acid (200 mg)
|
|
|
Lamivudine (200 mg)
|
|
|
Lamivudine Resolution Mixture A (10 mg)
|
|
|
Lamivudine Resolution Mixture B (10 mg) (This is a mixture of lamivudine (about 94%) and lamivudine diastereomer (about 6%))
|
|
|
Lamivudine Resolution Mixture C (0.8 mg)
|
|
|
Lanolin (20 g)
|
|
|
Lauryl Alcohol (125 mg)
|
|
|
Lanolin Alcohols (5 g)
|
|
|
Lansoprazole (150 mg)
|
|
|
Lansoprazole Related Compound A (25 mg) (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole)
|
|
|
Lansoprazole Related Compound B (25 mg) (2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate)
|
|
|
Lauroyl Arginine (100 mg) (dodecanoylarginine hydrochloride)
|
|
|
Lauric Acid (500 mg)
|
|
|
Lauroyl Polyoxylglycerides 1500 (500 mg)
|
|
|
Leflunomide (200 mg)
|
|
|
Letrozole (200 mg)
|
|
|
Letrozole Related Compound A (25 mg) (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile)
|
|
|
L-Leucine (200 mg)
|
|
|
Leflunomide Related Compound A (100 mg) (4-(trifluoromethyl)aniline)
|
|
|
Leflunomide Related Compound B (20 mg) (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
|
|
|
Leflunomide Related Compound C (10 mg) (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)
|
|
|
Latanoprost (50 mg)
|
|
|
Latanoprost Related Compound A (50 mg) (Isopropyl (E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoate)
|
|
|
Latanoprost Related Compound B (25 mg) (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate)
|
|
|
Latanoprost Related Compound D (25 mg) (COLD SHIPMENT REQUIRED) (Isopropyl (Z)-7-{(1R,2R,3R,5S)-2-[(R)-5-phenyl-3-(triethylsilyloxy)pentyl]-3,5-bis(triethylsilyloxy)cyclopentyl}hept-5-enoate)
|
|
|
Latanoprost Related Compound E (25 mg) ((Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid)
|
|
|
Leucovorin Calcium (500 mg)
|
|
|
Levalbuterol Hydrochloride (200 mg)
|
|
|
Levalbuterol Related Compound A (30 mg) (4-(2-tert-Butylamino-ethyl)-2-hydroxymethyl-phenol)
|
|
|
Levalbuterol Related Compound B (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol)
販売終了
|
|
|
Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol)
|
|
|
Levalbuterol Related Compound D (30 mg) (5-[2-(tert-Butylamino)-1-hydroxyethyl]-2-hydroxybenzaldehyde sulfate (2:1) (salt))
|
|
|
Levalbuterol Related Compound E (30 mg) (4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(ethoxymethyl)phenol)
|
|
|
Levalbuterol Related Compound F (30 mg) ((R)-1-[4-(Benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol)
|
|
|
Levalbuterol Related Compound H (10 mg) (4-[2-(tert-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol acetate)
|
|
|
Levamisole Hydrochloride (125 mg)
|
|
|
Levetiracetam (200 mg)
|
|
|
Levetiracetam Related Compound A (20 mg) ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide)
|
|
|
Levetiracetam Related Compound B (20 mg) ((S)-2-aminobutanamide hydrochloride)
|
|
|
Levobunolol Hydrochloride (200 mg)
|
|
|
Levocabastine Hydrochloride (50 mg)
|
|
|
Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride)
|
|
|
Levocarnitine (400 mg)
|
|
|
Levocarnitine Related Compound A (100 mg) (2-Propen-1-aminium, 3-carboxy-N,N,N-trimethyl-, chloride)
|
|
|
Levocetirizine Amide (75 mg)
|
|
|
Levocetirizine Dihydrochloride (200 mg)
|
|
|
Levodopa (200 mg)
|
|
|
Levodopa Related Compound A (50 mg) (3-(2,4,5-Trihydroxyphenyl)-L-alanine) (COLD SHIPMENT REQUIRED)
|
|
|
Levofloxacin (200 mg)
|
|
|
Levofloxacin Related Compound A (25 mg) ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
|
|
|
Levofloxacin Related Compound B (35 mg) ((S)-9,10,difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
|
|
|
Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate)
|
|
|
Levofloxacin Related Compound E (25 mg) ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride)
|
|
|
Levofloxacin Related Compound F (25 mg) ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
|
|
|
Levomenol (100 mg)
|
|
|
Levonordefrin (200 mg)
|
|
|
Levonorgestrel (125 mg)
|
|
|
Levothyroxine (500 mg)
|
|
|
Levothyroxine for Peak Identification (levothyroxine sodium spiked with liothyronine, triiodothyroacetic acid, tetraiodothyroacetic acid)
販売終了
|
|
|
Levothyroxine Sodium (50 mg)
|
|
|
Lidocaine (250 mg)
|
|
|
Lidocaine Hydrochloride (150 mg)
|
|
|
Lidocaine Related Compound H (50 mg) (2-Chloro-N-(2,6-dimethylphenyl)acetamide)
|
|
|
Lincomycin Hydrochloride (200 mg)
|
|
|
Linezolid (200 mg)
|
|
|
Linezolid Related Compound A (20 mg) ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
|
|
|
Linezolid Related Compound B (20 mg) ((S)-N-{[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide)
|
|
|
Linezolid Related Compound C (20 mg) ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
|
|
|
Linezolid Related Compound D (20 mg) ((R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl methanesulfonate)
|
|
|
Linezolid R-Isomer (20 mg) (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide)
|
|
|
Linoleyl Alcohol (5 X 30 mg)
|
|
|
Linolenyl Alcohol (5 x 30 mg)
|
|
|
Linoleoyl Polyoxylglycerides (150 mg)
|
|
|
Liothyronine (250 mg)
|
|
|
Alpha Lipoic Acid (500 mg)
|
|
|
Lisinopril (300 mg)
|
|
|
Lisinopril Related Compound A (250 mg) ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-alpha]pyrazin-2(1H)-yl}-4-phenylbutanoic acid)
|
|
|
Lithium Carbonate (300 mg)
|
|
|
Lithol Rubine BK (100 mg) (2-Naphthalenecarboxylic acid, 3-hydroxy-4-[(E)-2-(4-methyl-2-sulfophenyl)diazenyl]-, calcium salt (1:1))
|
|
|
Lomustine (200 mg)
|
|
|
Lomustine Related Compound B (25 mg) (1-(2-Chloroethyl)-3-cyclohexylurea)
|
|
|
Lomustine Related Compound C (25 mg) (1,3-Dicyclohexylurea)
|
|
|
Lomustine Related Compound D (25 mg) (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea)
|
|
|
Lonicera Japonica Flower Dry Extract (500 mg)
|
|
|
Lonicera Macranthoides Flower Dry Extract (500 mg) (Mixture, with identified compendial components Dipsacoside B, Macranthoidin A and Macranthoidin B)
|
|
|
Loperamide Hydrochloride (200 mg)
|
|
|
Loperamide Related Compound F (25 mg) (1r,4s)-4-(4-Chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidine 1-oxide hydrate)
|
|
|
Lopinavir (350 mg)
|
|
|
Lopinavir System Suitability Mixture (10 mg)
|
|
|
ロラカルベフ
販売終了
|
|
|
Loracarbef L-Isomer
販売終了
|
|
|
Loratadine Related Compound C (15 mg) (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
|
|
|
Loratadine (200 mg)
|
|
|
Loratadine Related Compound A (15 mg) (8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)
|
|
|
Loratadine Related Compound B (15 mg) (8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine)
|
|
|
Lorazepam Related Compound A (25 mg) (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepin-2-one)
|
|
|
Lorazepam Related Compound B (25 mg) (2-Amino-2',5-dichlorobenzophenone)
|
|
|
Lorazepam Related Compound C (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde)
|
|
|
Lorazepam Related Compound D (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid)
|
|
|
Lorazepam Related Compound E (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
|
|
|
Losartan Potassium (150 mg)
|
|
|
Losartan Related Compound A (20 mg) (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde)
|
|
|
Losartan Related Compound B (20 mg) (2-Butyl-4-chloro-(1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate)
|
|
|
Losartan Related Compound C (20 mg) (2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-carbaldehyde)
|
|
|
Losartan Related Compound D (20 mg) (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
|
|
|
Losartan Related Compound E (20 mg) (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
|
|
|
Lovastatin (125 mg)
|
|
|
Lovastatin Related Compound A (20 mg) (4,4a-Dihydrolovastatin)
|
|
|
Lovastatin Impurity Identification Mixture (30 mg)
|
|
|
Loxapine Succinate (125 mg)
|
|
|
Loxapine Related Compound A (20 mg) (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine)
|
|
|
Lufenuron Related Compound B (15 mg) (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide)
|
|
|
Lufenuron Related Compound C (15 mg) (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide)
|
|
|
Lumefantrine (100 mg)
|
|
|
Lumefantrine Related Compound A (25 mg) ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride)
|
|
|
Lufenuron (200 mg)
|
|
|
Lufenuron Related Compound G (15 mg) (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate)
|
|
|
Lutein (3 X 50 mg)
|
|
|
Luteolin 7-O-Glucoside (30 mg) (2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside)
|
|
|
Lynestrenol (20 mg) ((17alpha) -19-Norpregn-4-en-20-yn-17-ol)
|
|
|
L-Lysine Acetate (200 mg)
|
|
|
L-Lysine Hydrochloride (200 mg)
|
|
|
Levodopa Related Compound B (50 mg) (3-methoxytyrosine)
|
|
|
Low Molecular Weight Heparin Molecular Weight Calibrant (10.6 mg)
|
|
|
L-Theanine (200 mg)
|
|
|
Lypressin (2 mg) (8-L-lysine vasopressin) (COLD SHIPMENT REQUIRED)
|
|
